See the latest Coronavirus Information including vaccinations, testing sites, visitation restrictions, and more.
There is no publicly available rating for this medical professional for one of the following reasons:
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
3400 Spruce Street
Philadelphia, PA 19104
Dr. Nabavizadeh is currently the principal investigator of multiple imaging clinical trials in patients with brain tumors. His research efforts involve multimodality imaging using structural and physiologic MRI imaging with additional PET probes and molecular imaging techniques to better understand the complex nature of brain tumor microenvironment. The ultimate goal of his research is to use imaging and liquid biopsy biomarkers in prognostication, tumor response evaluation, differentiation of tumor progression from treatment-effect.
Nabavizadeh SA, Ware JB, Guiry S, Nasrallah MP, Mays JJ, Till JE, Hussain J, Abdalla A, Yee SS, Binder ZA, O'Rourke DM, Brem S, Desai AS, Wolf R, Carpenter EL, Bagley SJ.: Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma Neurooncol Adv 2 (1): 2020 .
Jillian W Lazor, Joel M Stein, James Eric Schmitt, Kathryn A Davis, Seyed Ali Nabavizadeh: Epilepsy Lesion Localization is not Predicted by Developmental Venous Anomaly Location or its FDG-PET Metabolic Activity J Neuroimaging
30 (4): 544-550,2020.
Srikant Kamesh Iyer, Brianna Moon, Kosha Ruparel, David Roalf, Jae Song, M, Samantha Guiry, Jeffrey Ware, Kurtz R, Nicholas Josselyn, Sanjeev Chawla, S. Ali Nabavizadeh, Walter R. Witschey: Data-driven quantitative susceptibility mapping using loss adaptive dipole inversion (LADI) Journal of Magnetic Resonance Imaging : 2020.
Henderson F, Brem S, O’Rourke DM, Nasrallah M, Buch VP, Young A, Doot R, Pantel A, Desai A, Bagley S, Nabavizadeh SA: 18F-fluciclovine PET to distinguish treatment related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides
neurosurgical sampling Neuro-Oncology Practice : 2020.
Lazor J, Schmitt JE, Loevner LA, Nabavizadeh SA: Metabolic changes of brain developmental venous anomalies on 18F-FDG-PET Academic Radiology 26 (4): 443-449,2019 .
Bagley S, Nabavizadeh SA, Mays J, Till JE, Ware J, Levy S, Sarchiapone W, Hussain J, Prior TJ, Guiry S, Christensen T, Yee SS, Nasrallah M, Morrissette JJ, Binder Z, O'Rourke DM, Cucchiara AJ, Brem S, Desai AS, Carpenter EL: Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma - a pilot prospective study. Clin Cancer Res. : 2019.
Kuan EC, Rereddy SK, Patel NN, Maina IW, Triantafillou V, Kohanski MA, Tong CCL, Nabavizadeh SA, Lee JYK, Grady MS, O'Malley BW Jr, Palmer JN2, Adappa ND.: Asymptomatic radiographic sinonasal inflammation does not affect pituitary surgery outcomes. Laryngoscope 129 (7): 1545-1548,2019.
Cox M, Kung D, Hurst RW, Bagley LJ, Nabavizadeh SA.: Significance of the absent vertebral artery T2 flow void on cervical spine MRI in atraumatic patients without acute neurological symptoms. Neuroradiol J 32 (3): 154-157,2019.
Nabavizadeh SA, Akbari H, Ware JB, Nasrallah M, Guiry S, Bagley SJ, Desai A, Levy S, Sarchiapone W, Prior T, Detre J, Wolf RL, O'Rourke DM, Brem S, Davatzikos C: Arterial Spin Labeling and Dynamic Susceptibility Contrast-enhanced MR Imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma. Sci Rep 9 (1): 2019.
Chawla S, Wang S, Mohan S, Nasrallah M, Verma G, Brem S, O'Rourke DM, Wolf RL, Poptani H, Nabavizadeh SA.: Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI. J Magn Reson Imaging 49 (1): 184-194,2019.
Hospital of the University of PennsylvaniaDepartment of Radiology3400 Spruce Street